Lobe Financial Statements From 2010 to 2024
| LOBEF Stock | USD 0.02 0.02 882.61% |
Check Lobe Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lobe Sciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . Lobe financial statements analysis is a perfect complement when working with Lobe Sciences Valuation or Volatility modules.
Lobe |
Lobe Sciences OTC Stock Return On Asset Analysis
Lobe Sciences' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Lobe Sciences Return On Asset | -0.65 |
Most of Lobe Sciences' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lobe Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Lobe Sciences has a Return On Asset of -0.6505. This is 92.57% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on asset for all United States stocks is notably higher than that of the company.
Lobe Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Lobe Sciences's current stock value. Our valuation model uses many indicators to compare Lobe Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lobe Sciences competition to find correlations between indicators driving Lobe Sciences's intrinsic value. More Info.Lobe Sciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lobe Sciences' earnings, one of the primary drivers of an investment's value.About Lobe Sciences Financial Statements
Lobe Sciences stakeholders use historical fundamental indicators, such as Lobe Sciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although Lobe Sciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Lobe Sciences' assets and liabilities are reflected in the revenues and expenses on Lobe Sciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Lobe Sciences. Please read more on our technical analysis and fundamental analysis pages.
Lobe Sciences Ltd., a life sciences company, focuses on the research and development of psychedelic medicines. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Lobe OTC Stock
Lobe Sciences financial ratios help investors to determine whether Lobe OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lobe with respect to the benefits of owning Lobe Sciences security.